About ATC 2019

2019 ATC conference focuses on understanding the antibody drug conjugates, cancer immune therapy and cell therapy, in which the meeting is organized to highlight recent insights into the complex roles of high potency drug precisely targeting cancer cells, immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of checkpoint blocking strategies, modulation of tumor microenvironment, and adoptive cell therapeutics approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients.

We sincerely thank you for supporting the ATC and bringing your expertise to build a better tomorrow of the world well-being. We wish you a pleasant experience in Taiwan and the ATC 2019.